SIC 2833 – Medicinal Chemicals and Botanical Products
| Valuation | |
|---|---|
| Market Cap ($M) | 147.19 |
| Enterprise Value ($M) | 156.69 |
| Book Value ($M) | 34.16 |
| Book Value / Share | 7.43 |
| Price / Book | 4.31 |
| NCAV ($M) | -6.33 |
| NCAV / Share | -1.38 |
| Price / NCAV | -23.25 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | 0.17 |
| Return on Assets (ROA) | 0.19 |
| Return on Equity (ROE) | 0.33 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 0.64 |
| Current Ratio | 1.50 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 18.10 |
| Assets | 58.59 |
| Liabilities | 24.43 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 1,918 | 12,957 | 14.80 | |
| 1,512 | 5,689 | 26.58 | |
| 686 | 10,466 | 6.55 | |
| 1,721 | 13,224 | 13.01 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| FBRX – Forte Biosciences, Inc. | FENC – Fennec Pharmaceuticals Inc. |
| FLGC – Flora Growth Corp. | GALT – Galectin Therapeutics Inc. |
| GDTC – CytoMed Therapeutics Limited |
Financial data and stock pages provided by
Fintel.io